Statins and Risk of Cholangiocarcinoma: A Systematic Review and Meta-analysis

被引:4
作者
Wijarnpreecha, Karn [1 ]
Aby, Elizabeth S. [2 ]
Ghoz, Hassan [1 ]
Cheungpasitporn, Wisit [3 ]
Lukens, Frank J. [1 ]
Harnois, Denise M. [1 ]
Ungprasert, Patompong [4 ]
机构
[1] Mayo Clin, Div Gastroenterol & Hepatol, Coll Med, Jacksonville, FL USA
[2] Univ Minnesota, Div Gastroenterol & Hepatol, Minneapolis, MN USA
[3] Univ Mississippi, Dept Med, Div Nephrol, Med Ctr, Jackson, MS USA
[4] Cleveland Clin, Dept Rheumat & Immunol Dis, Cleveland, OH USA
关键词
statins; bile duct cancer; biliary tract cancer; cholangiocarcinoma; meta-analysis; BILIARY-TRACT CANCERS; INTRAHEPATIC CHOLANGIOCARCINOMA; METABOLIC SYNDROME; UNITED-STATES; DIAGNOSIS; PATHOGENESIS; SIMVASTATIN; APOPTOSIS; MORTALITY; RECEPTOR;
D O I
10.15403/jgld-2990
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: The use of statins has been shown to be associated with a decreased risk of cholangiocarcinoma (CCA) in many studies although the results have been inconsistent. We conducted this systematic review and meta-analysis to further investigate this possible association by identifying all relevant studies and combining their results together. Methods: A comprehensive literature review was conducted utilizing the MEDIA NE and EMBASE databases through March 2020 to identify all studies that compared the risk of CCA among individuals who use statins with individuals who do not use statins. Effect estimates from each study were extracted and combined using the random-effect, generic inverse variance method of DerSimonian and Laird. Results: A total of seven studies with 6,251,187 participants fulfilled the eligibility criteria and were included in this meta-analysis. The pooled analysis found a significantly decreased risk of CCA among individuals who use statins compared with individuals who do not use statins with the pooled odds ratio of 0.68 (95% CI: 0.52-0.89; 12 96%). Conclusions: The current systematic review and meta-analysis found a significant association between the use of statins and a decreased risk of CCA.
引用
收藏
页码:629 / 635
页数:7
相关论文
共 33 条
[1]   A candidate targeting molecule of insulin-like growth factor- I receptor for gastrointestinal cancers [J].
Adachi, Yasushi ;
Yamamoto, Hiroyuki ;
Ohashi, Hirokazu ;
Endo, Takao ;
Carbone, David P. ;
Imai, Kohzoh ;
Shinomura, Yasuhisa .
WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (46) :5779-5789
[2]   Involvement of RhoA/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in vitro [J].
Amerongen, GPV ;
Koolwijk, P ;
Versteilen, A ;
van Hinsbergh, VWM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (02) :211-217
[3]   Serum lipid levels and the risk of biliary tract cancers and biliary stones: A population-based study in China [J].
Andreotti, Gabriella ;
Chen, Jinbo ;
Gao, Yu-Tang ;
Rashid, Asif ;
Chang, Shih-Chen ;
Shen, Ming-Chang ;
Wang, Bing-Sheng ;
Han, Tian-Quan ;
Zhang, Bai-He ;
Danforth, Kim N. ;
Althuis, Michelle D. ;
Hsing, Ann W. .
INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (10) :2322-2329
[4]  
[Anonymous], 2000, The NewcastleOttawa Scale (NOS) for assessing the quality of nonrandomised studies in metaanalyses
[5]   Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment [J].
Blechacz, Boris ;
Gores, Gregory J. .
HEPATOLOGY, 2008, 48 (01) :308-321
[6]   Clinical diagnosis and staging of cholangiocarcinoma [J].
Blechacz, Boris ;
Komuta, Mina ;
Roskams, Tania ;
Gores, Gregory J. .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2011, 8 (09) :512-522
[7]   The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis [J].
Blum, A. ;
Shamburek, R. .
ATHEROSCLEROSIS, 2009, 203 (02) :325-330
[8]   Simvastatin and atorvastatin as inhibitors of proliferation and inducers of apoptosis in human cholangiocarcinoma cells [J].
Buranrat, Benjaporn ;
Senggunprai, Laddawan ;
Prawan, Auemduan ;
Kukongviriyapan, Veerapol .
LIFE SCIENCES, 2016, 153 :41-49
[9]   Risk Factors for Intrahepatic Cholangiocarcinoma: Association Between Metformin Use and Reduced Cancer Risk [J].
Chaiteerakij, Roongruedee ;
Yang, Ju Dong ;
Harmsen, William S. ;
Slettedahl, Seth W. ;
Mettler, Teresa A. ;
Fredericksen, Zachary S. ;
Kim, W. Ray ;
Gores, Gregory J. ;
Roberts, Rosebud O. ;
Olson, Janet E. ;
Therneau, Terry M. ;
Roberts, Lewis R. .
HEPATOLOGY, 2013, 57 (02) :648-655
[10]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188